Back to search

A Phase 1 Study, in Cystic Fibrosis Patients, of the Safety, Toxicity, and Biological Efficacy of a Single Administration of a Replication Deficient, Recombinant Adenovirus Carrying the cDNA of the Normal Cystic Fibrosis Transmembrane Conductance Regulator Gene in the Lung. National Institutes of Health, Bethesda, Maryland

Data up to Jan 2025

Published1995
Citations68
References0

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

Loading...
A Phase 1 Study, in Cystic Fibrosis Patients, of the Safety, Toxicity, and Biological… (1995) – Human Gene Therapy | Metascience Observatory Explorer